CITPRIZMA Trademark

Trademark Overview

On Tuesday, July 24, 2018, a trademark application was filed for CITPRIZMA with the United States Patent and Trademark Office. The USPTO has given the CITPRIZMA trademark a serial number of 88049789. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by Gambro Lundia AB. The CITPRIZMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration
citprizma

General Information

Serial Number88049789
Word MarkCITPRIZMA
Filing DateTuesday, July 24, 2018
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5817892
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements

Goods and ServicesPharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGambro Lundia AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLund SE-22643
SE
Party NameGambro Lundia AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLund SE-22643
SE
Party NameGambro Lundia AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLund SE-22643
SE

Trademark Events

Event DateEvent Description
Tuesday, November 13, 2018LETTER OF SUSPENSION E-MAILED
Friday, July 27, 2018NEW APPLICATION ENTERED
Friday, July 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 10, 2018ASSIGNED TO EXAMINER
Tuesday, November 13, 2018SUSPENSION LETTER WRITTEN
Tuesday, November 13, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 29, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, December 4, 2018ASSIGNED TO LIE
Tuesday, December 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Friday, May 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 18, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 18, 2019NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 26, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, June 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 10, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

citprizma dialysis fluids being hemodialysis hemofiltration hemodiafiltration concentrates substitution solutions namely